Variant report
Variant | nsv974189 |
---|---|
Chromosome Location | chr13:67983069-67986271 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568533535 | chr13:67983120-67983121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144060751 | chr13:67983148-67983149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541817512 | chr13:67983163-67983164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73507060 | chr13:67983177-67983178 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs201945227 | chr13:67983182-67983183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535976679 | chr13:67983190-67983191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527318496 | chr13:67983197-67983198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548067352 | chr13:67983227-67983228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571061835 | chr13:67983248-67983249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138740065 | chr13:67983254-67983255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188683657 | chr13:67983266-67983267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569789438 | chr13:67983281-67983282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535535268 | chr13:67983296-67983297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1173112 | chr13:67983298-67983299 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs180827640 | chr13:67983355-67983356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534754139 | chr13:67983368-67983369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553983930 | chr13:67983372-67983373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186278808 | chr13:67983400-67983401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539584423 | chr13:67983442-67983443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553728085 | chr13:67983443-67983444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201303134 | chr13:67983447-67983448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375513944 | chr13:67983535-67983536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576332171 | chr13:67983568-67983569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189192327 | chr13:67983627-67983628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74093750 | chr13:67983684-67983685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572024772 | chr13:67983707-67983708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545918947 | chr13:67983710-67983711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182232647 | chr13:67983711-67983712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542796987 | chr13:67983744-67983745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76850437 | chr13:67983766-67983767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564767551 | chr13:67983793-67983794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1185357 | chr13:67983815-67983816 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs576691923 | chr13:67983928-67983929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111555906 | chr13:67983970-67983971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs146045235 | chr13:67984014-67984015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112356437 | chr13:67984030-67984031 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549060745 | chr13:67984097-67984098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113959975 | chr13:67984147-67984148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111975120 | chr13:67984170-67984171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1937536 | chr13:67984180-67984181 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs551498535 | chr13:67984181-67984182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142332662 | chr13:67984222-67984223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs34081100 | chr13:67984239-67984240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539331797 | chr13:67984253-67984254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374358745 | chr13:67984303-67984304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1781607 | chr13:67984313-67984314 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs113211715 | chr13:67984336-67984337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs186494739 | chr13:67984379-67984380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555463490 | chr13:67984419-67984420 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572062864 | chr13:67984420-67984421 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:67982400-67983400 | Enhancers | Fetal Brain Male | brain |
2 | chr13:67982800-67983200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr13:67982800-67983200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:67982800-67983200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr13:67982800-67983200 | Enhancers | HepG2 | liver |
6 | chr13:67982800-67983400 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr13:67982800-67983400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr13:67983000-67983200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr13:67983000-67983200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:67983000-67983400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr13:67983400-67984600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr13:67983400-67984800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
13 | chr13:67983400-67984800 | Weak transcription | Fetal Brain Male | brain |
14 | chr13:67983600-67984400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr13:67984000-67985400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr13:67984200-67984400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
17 | chr13:67984400-67985400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
18 | chr13:67984600-67985400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr13:67984600-67985600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr13:67984800-67985000 | Enhancers | Fetal Brain Male | brain |
21 | chr13:67984800-67985400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
22 | chr13:67985000-67985200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
23 | chr13:67985200-67985400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |